The present invention relates to crystalline form of Eltrombopag free acid and its process for preparation.
-
Page/Page column 13
(2016/05/02)
Regulated activation of cell-membrane receptors by metal-chelating agonists
Invented is a regulated activation of cell-membrane receptors by small molecule agents. Also invented is a method to render a cell-membrane receptor responsive to the activation by small molecule compounds by specific single point mutations in the transmembrane region.
-
(2008/06/13)
Thrombopoietin mimetics
Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.
-
Page 17
(2008/06/13)
Thrombopoietin mimetics
Invented are non-peptide TPO mimetics. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected azo-pyrazole derivative.
-
(2008/06/13)
More Articles about upstream products of 277299-70-4